Eris Lifesciences Limited
NSE:ERIS.NS
1459 (INR) • At close May 9, 2025
Overview | Financials
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) INR.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operationele Activiteiten: | ||||||||||||
| Nettowinst
| 3,919.83 | 4,046.43 | 4,421.98 | 3,944.97 | 3,313.5 | 3,173.58 | 3,122.29 | 2,637.72 | 1,544.44 | 1,094.15 | 983.25 | 831.39 |
| Afschrijvingen & Amortisatie
| 1,826.05 | 1,170.88 | 647.05 | 429.85 | 502.58 | 363.54 | 256.42 | 237.39 | 203.56 | 155.14 | 47.68 | 34.85 |
| Uitgestelde Inkomstenbelasting
| 0 | -809.69 | -976.58 | -670.94 | -585.06 | -980.19 | 0 | 0 | 0 | 0 | 0 | 0 |
| Aandelen Gebaseerde Vergoedingen
| 7.5 | 31.21 | 13.55 | 11.2 | 16.61 | 16.52 | 0 | 0 | 0 | 0 | 0 | 0 |
| Verandering in Werkkapitaal
| -987.39 | -1,755.36 | -299.01 | 53.27 | -527.06 | -532.38 | -221.54 | -163.65 | -82.05 | -80.63 | 207.26 | -160.5 |
| Vorderingen
| -570.93 | -1,171.38 | -204.8 | 158.96 | -747.86 | -175.54 | -91.59 | -138.36 | -17.03 | -13.26 | -57.44 | -21.5 |
| Voorraden
| -169.4 | 47.44 | -234.45 | -249.91 | 131.78 | -172.05 | 4.16 | -37.25 | 99.83 | -127.94 | -16.13 | -206.27 |
| Crediteuren
| 909.78 | -104.97 | 151.59 | 25.66 | 159.34 | 55.09 | 270.08 | 84.28 | 0 | 0 | 0 | 0 |
| Overig Werkkapitaal
| -1,156.84 | -526.45 | -11.35 | 118.56 | -70.32 | -239.88 | -225.7 | -126.4 | -181.88 | 47.31 | 223.39 | 45.77 |
| Overige Niet-Contante Posten
| 94.06 | 233.91 | -24.35 | -14.74 | -9.47 | 188.89 | -810.82 | -712.81 | -351.16 | -268.09 | -341.95 | -325.59 |
| Kasstroom uit Operationele Activiteiten
| 4,860.05 | 2,917.38 | 3,782.64 | 3,753.61 | 2,711.1 | 2,229.96 | 2,346.35 | 1,998.65 | 1,314.79 | 900.57 | 896.24 | 380.15 |
| Investeringsactiviteiten: | ||||||||||||
| Investeringen in Materiële Vaste Activa
| -1,291.63 | -8,414.21 | -1,210.33 | -257.63 | -1,512.82 | -380.02 | -250.96 | -497.47 | -236.41 | -130.84 | -519.33 | -78.43 |
| Netto Overnames
| -5,668 | -6,554.91 | -102.95 | -2.81 | -213.73 | -30.73 | -5,279.58 | 35 | 0.3 | 0 | 0 | 0 |
| Aankoop van Beleggingen
| 0 | -300 | -2,677.73 | -3,733.92 | -381 | -447.67 | -1,074.69 | -1,394.84 | -207.23 | -792.91 | -332.32 | -328.41 |
| Verkoop/verval van Beleggingen
| 484.06 | 5,204.39 | 795.87 | 774.2 | 3,260.79 | 797.3 | 694.56 | 7.7 | 0 | 0 | 21.94 | 36.56 |
| Overige Investeringsactiviteiten
| -12,069.65 | 243.72 | -0.96 | -13.42 | 79.64 | 10.61 | 9.7 | 17.02 | 4.51 | 2.42 | 2.28 | 13.59 |
| Kasstroom uit Investeringsactiviteiten
| -18,545.22 | -9,821.01 | -3,196.1 | -3,233.58 | 1,232.88 | -50.51 | -5,900.97 | -1,841.1 | -439.13 | -921.33 | -827.43 | -356.69 |
| Financieringsactiviteiten: | ||||||||||||
| Schuldaflossingen
| 14,636.99 | 8,178 | 335 | 0.1 | -86.02 | -2,002.14 | 3,734.74 | -65.09 | -5 | 4.75 | -20.58 | -24.07 |
| Uitgifte van Gewone Aandelen
| 45.43 | 22.78 | 71.96 | 0 | 0 | 8.92 | 0 | 0 | 0 | 0 | 0 | 0 |
| Terugkoop van Gewone Aandelen
| 0 | 0 | 0 | 0 | -1,016.77 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Uitgekeerde Dividenden
| 0 | -999.11 | -816.23 | -746.79 | -469.79 | 0 | 0 | -169.12 | -830.78 | 0 | 0 | 0 |
| Overige Financieringsactiviteiten
| -884.63 | -321.42 | 34.24 | -77.26 | -1,773.33 | -217.31 | -102.62 | -2.42 | -1.2 | -0.18 | -2.46 | -7.12 |
| Kasstroom uit Financieringsactiviteiten
| 13,797.79 | 6,880.25 | -446.99 | -823.95 | -3,345.91 | -2,210.53 | 3,632.12 | -236.63 | -836.98 | 4.57 | -23.04 | -31.19 |
| Overige Informatie: | ||||||||||||
| Effect van Wisselkoersveranderingen op Kas
| 0 | 74.9 | 0 | 0 | 0 | 0 | 5.15 | 0 | 0 | 0 | 0 | 0 |
| Netto Kasstroomverandering
| 382.23 | 51.52 | 139.55 | -303.92 | 598.07 | -31.08 | 82.65 | -65.25 | 38.68 | -16.19 | 45.77 | -7.73 |
| Kaspositie aan het Einde van de Periode
| 942.45 | 560.22 | 508.7 | 369.15 | 673.07 | 75 | 106.08 | 23.42 | 88.67 | 49.99 | 66.18 | 20.41 |